시장보고서

상품코드

1552565

약물 전달 및 유전자 전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 지역별, 부문별 예측(2024-2030년)

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

약물 전달 및 유전자 전달 기기(Drug And Gene Delivery Devices) 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 약물 전달 및 유전자 전달 세계 시장 규모는 2024년부터 2030년까지 CAGR 9.0%로 추이하며 성장 할 것으로 예상되며, 2030년에는 12억 2,000만 달러에 달할 것으로 예측됩니다.

환자 수요에 부응하고 최소한의 약품으로 생체 이용률을 향상시키기 위해 혁신적인 약물 전달 시스템을 개발하기 위해 시장 진출기업의 투자가 증가하고 있음 원동력이 되고 있습니다. 게다가 광범위한 질병의 치료에 있어서 유전자 치료의 높은 성장 가능성을 배경으로 유전자 전달 시스템의 연구개발에 대한 주목이 높아지고 있는 것도 향후 시장 성장에 박차를 가할 것으로 예상됩니다.

약물 전달 시스템은 환자의 선호도 변화와 함께 끊임없이 진화하고 있습니다. 예를 들어, 호르몬 보충 요법은 처음에는 정제 형태로 널리 처방되었지만 현재는 미리 채워진 주사기, 패치, 질 링, 젤 및 스프레이의 형태로 사용할 수 있습니다. 다양한 형태의 전달 시스템을 개발하는 주요 목적은 사용 용이성을 향상시키는 것입니다. 약물전달 시스템을 설계할 때 전달 시스템의 미관, 가격, API 양 등 요소도 고려됩니다.

Drag Delivery 및 Gene Delivery Device 시장 보고서 하이라이트 :

2023년 경구부문은 시장을 독점했으며 편의성과 투여의 용이성으로 52.7%의 최대 매출 점유율을 차지했습니다.
주사제 부문은 생명을 위협하는 질병의 유병률 증가와 주사제 약물 전달 기기의 진보에 추진되어 예측 기간 동안 11.0%의 가장 빠른 CAGR이 예상됩니다.
2023년 북미는 만성질환으로 고통받는 사람들 증가로 54.0%의 매출 점유율로 약물 전달 및 유전자 전달 시장을 독점했습니다.
아시아 태평양의 약물전달 시장은 예측 기간 동안 성장할 것으로 예상됩니다. 이 성장은 라이프 스타일 변화, 알코올 및 담배 소비량 증가로 심장병, 당뇨병, 암 등 만성 질환의 유병률이 증가하고 있기 때문입니다.

약물 전달 및 유전자 전달 기기 시장 점유율, 지역별(2023년, 2030년)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아 태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
남미
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제7장 경쟁 구도

주요 시장 진출기업의 최근 동향 및 영향 분석
기업 분류
기업 히트맵 분석
기업 프로파일
- Uniqure NV,
- SiBiono GeneTech Co.
- Epeius Biotechnologies Corporation
- Shanghai Sunway Biotech Co., Ltd
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson and Johnson
- Novartis AG
- Bayer AG
- Becton, Dickinson and Company

LYJ

Drug And Gene Delivery Devices Market Growth & Trends:

The global drug and gene delivery devices market size is expected to reach USD 1.22 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising investment by the market players to develop innovative drug delivery systems to cater to the demand by the patients as well as to increase the bioavailability at minimum quantity of active pharmaceutical ingredient is driving the market growth. Additionally, increasing focus on R&D of gene delivery systems owing to the high growth potential of gene therapy for the treatment of a wide range of diseases is expected to fuel the market growth in the future.

Drug delivery systems are in a constant evolution along with the changing preference by the patient. For instance, initially, hormone replacement therapy was widely prescribed in the form of pills, whereas, it is now available in the form of prefilled syringes, patches, vaginal rings, gel, and sprays. The principal purpose of development of different forms of delivery systems is to increase the ease of use. Factors such as aesthetics of the delivery systems, price, and amount of API are also considered while designing the drug delivery system.

Drug And Gene Delivery Devices Market Report Highlights:

In 2023, the oral segment dominated the market and accounted for the largest revenue share of 52.7%, owing to its convenience and ease of administration.
The injectable segment is expected to witness the fastest CAGR of 11.0% during the forecast period, fueled by increasing prevalence of life-threatening diseases and advancement in injectable drug delivery devices.
In 2023, North America dominated the drug and gene delivery devices market with a revenue share of 54.0%, owing to the rising number of people suffering from chronic diseases.
The drug and gene delivery devices market in Asia Pacific is projected to witness growth during the forecast period. The growth can be attributed to the increasing prevalence of chronic diseases such as heart disease, diabetes and cancer owing to the changing lifestyle, increase in consumption of alcohols and cigarettes.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Drug and Gene Delivery Devices Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Drug and Gene Delivery Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Drug and Gene Delivery Devices Market: Route of Administration Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Drug and Gene Delivery Devices: Route of Administration Outlook Analysis, 2023 & 2030 (USD Million)
4.3. Oral
- 4.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Inhalation
- 4.4.1. Inhalation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Transdermal
- 4.5.1. Transdermal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Injectable
- 4.6.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Ocular
- 4.7.1. Ocular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Nasal
- 4.8.1. Nasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Topical
- 4.9.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Drug and Gene Delivery Devices Market: Vector Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Drug and Gene Delivery Devices Market: Vector Analysis, 2023 & 2030 (USD Million)
5.3. Viral
- 5.3.1. Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Non-Viral
- 5.4.1. Non-Viral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Drug and Gene Delivery Devices Market: Regional Estimates & Trend Analysis

6.1. Drug and Gene Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. U.K.
  - 6.3.2.1. U.K. Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Sweden Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Japan
  - 6.4.2.1. Japan Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. China
  - 6.4.3.1. China Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. Australia
  - 6.4.5.1. Australia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. South Korea
  - 6.4.6.1. South Korea Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
- 6.6.1. Middle East and Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
  - 6.6.2.1. South Africa Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
  - 6.6.3.1. Saudi Arabia Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. UAE
  - 6.6.4.1. UAE Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Drug and Gene Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Uniqure N.V.,
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. SiBiono GeneTech Co.
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Epeius Biotechnologies Corporation
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Shanghai Sunway Biotech Co., Ltd
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Pfizer, Inc.
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. F. Hoffmann-La Roche Ltd.
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
- 7.4.7. Johnson and Johnson
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Novartis AG
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Bayer AG
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
- 7.4.10. Becton, Dickinson and Company
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives

약물 전달 및 유전자 전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 지역별, 부문별 예측(2024-2030년)

Drug And Gene Delivery Devices Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Inhalation, Transdermal), By Vector (Viral, Non-Viral), By Region, And Segment Forecasts, 2024 - 2030

약물 전달 및 유전자 전달 기기(Drug And Gene Delivery Devices) 시장 성장 및 동향 :

Drag Delivery 및 Gene Delivery Device 시장 보고서 하이라이트 :

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 약물 전달 및 유전자 전달 기기 시장 변수, 동향, 범위

제4장 약물 전달 및 유전자 전달 기기 시장 : 투여 경로별 추정·동향 분석

제5장 약물 전달 및 유전자 전달 기기 시장 : 벡터별 추정·동향 분석

제6장 약물 전달 및 유전자 전달 기기 시장 : 지역별 추정·동향 분석